Abbott Opens New Preclinical Lab In Singapore - Its First Pharma R&D Outpost In Southeast Asia
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Abbott opened a new preclinical laboratory in Singapore's Biopolis research park Jan. 20., which marked the company's first pharma R&D site in Southeast Asia. The new facility will conduct stability studies, including studies on active pharmaceutical ingredients and novel formulations to support global regulatory filings